TreeWAS – Variant ID: rs2523626

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	No effect posterior probability	Protective posterior probability
E03.9 Hypothyroidism, unspecified	0.000	1.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.000	1.000
E00-E07 Disorders of thyroid gland	0.000	1.000
E03 Other hypothyroidism	0.000	1.000
Chapter XII Diseases of the skin and subcutaneous tissue	0.000	1.000
# Top node	0.001	0.999
L40-L45 Papulosquamous disorders	0.003	0.997
L40 Psoriasis	0.003	0.997
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.005	0.995
Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.006	0.994
E65-E68 Obesity and other hyperalimentation	0.008	0.992
L57 Skin changes due to chronic exposure to nonionising radiation	0.009	0.991
L40.5 Arthropathic psoriasis	0.012	0.988
E66 Obesity	0.014	0.986
L40.9 Psoriasis, unspecified	0.015	0.985
E66.8 Other obesity	0.016	0.984
D50-D53 Nutritional anaemias	0.016	0.984
L57.0 Actinic keratosis	0.017	0.983
M06.9 Rheumatoid arthritis, unspecified	0.019	0.981
D50 Iron deficiency anaemia	0.020	0.980
M06 Other rheumatoid arthritis	0.021	0.979
M05-M14 Inflammatory polyarthropathies	0.023	0.977
D50.9 Iron deficiency anaemia, unspecified	0.024	0.976
Chapter XIII Diseases of the musculoskeletal system and connective tissue	0.025	0.975
Chapter I Certain infectious and parasitic diseases	0.026	0.974
L00-L08 Infections of the skin and subcutaneous tissue	0.028	0.972
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.030	0.970
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.032	0.968
B35-B49 Mycoses	0.034	0.966
B37 Candidiasis	0.037	0.963
B37.8 Candidiasis of other sites	0.040	0.960
E70-E90 Metabolic disorders	0.040	0.960
Chapter VIII Diseases of the ear and mastoid process	0.042	0.958
L02 Cutaneous abscess, furuncle and carbuncle	0.043	0.957
L02.2 Cutaneous abscess, furuncle and carbuncle of trunk	0.052	0.948
H65-H75 Diseases of middle ear and mastoid	0.071	0.929
B25-B34 Other viral diseases	0.073	0.927
H72 Perforation of tympanic membrane	0.085	0.915
L20-L30 Dermatitis and eczema	0.085	0.915
E06 Thyroiditis	0.092	0.908
H72.9 Perforation of tympanic membrane, unspecified	0.094	0.906
B37.0 Candidal stomatitis	0.095	0.905
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.101	0.899
M07 Psoriatic and enteropathic arthropathies	0.104	0.896
M45-M49 Spondylopathies	0.107	0.893
D65-D69 Coagulation defects, purpura and other haemorrhagic conditions	0.111	0.889
B34 Viral infection of unspecified site	0.113	0.887
M45 Ankylosing spondylitis	0.118	0.882
E10-E14 Diabetes mellitus	0.122	0.878
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.122	0.878
M95-M99 Other disorders of the musculoskeletal system and connective tissue	0.127	0.873
M45.X9 Ankylosing spondylitis (Site unspecified)	0.133	0.867
Chapter V Mental and behavioural disorders	0.135	0.865
E05 Thyrotoxicosis [hyperthyroidism]	0.144	0.856
E10 Insulin-dependent diabetes mellitus	0.152	0.848
H65 Nonsuppurative otitis media	0.154	0.846
B34.9 Viral infection, unspecified	0.155	0.845
D50.0 Iron deficiency anaemia secondary to blood loss (chronic)	0.156	0.844
M07.3 Other psoriatic arthropathies	0.162	0.838
H80-H83 Diseases of inner ear	0.163	0.837
D80-D89 Certain disorders involving the immune mechanism	0.166	0.834
M95 Other acquired deformities of musculoskeletal system and connective tissue	0.167	0.833
E06.3 Autoimmune thyroiditis	0.168	0.832
E87 Other disorders of fluid, electrolyte and acid-base balance	0.170	0.830
E89.0 Postprocedural hypothyroidism	0.172	0.828
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.174	0.826
L29 Pruritus	0.175	0.825
M05 Seropositive rheumatoid arthritis	0.179	0.821
L08 Other local infections of skin and subcutaneous tissue	0.181	0.819
M35 Other systemic involvement of connective tissue	0.184	0.816
D68 Other coagulation defects	0.185	0.815
M35.3 Polymyalgia rheumatica	0.187	0.813
M20-M25 Other joint disorders	0.187	0.813
B20-B24 Human immunodeficiency virus [HIV] disease	0.190	0.810
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.194	0.806
L02.4 Cutaneous abscess, furuncle and carbuncle of limb	0.194	0.806
M95.0 Acquired deformity of nose	0.195	0.805
E86 Volume depletion	0.199	0.801
E20-E35 Disorders of other endocrine glands	0.202	0.798
M06.0 Seronegative rheumatoid arthritis	0.213	0.787
B35 Dermatophytosis	0.215	0.785
L29.0 Pruritus ani	0.217	0.783
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.218	0.781
D86 Sarcoidosis	0.229	0.771
B99-B99 Other infectious diseases	0.231	0.769
E05.0 Thyrotoxicosis with diffuse goitre	0.235	0.765
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.237	0.763
E27 Other disorders of adrenal gland	0.237	0.763
E87.1 Hypo-osmolality and hyponatraemia	0.237	0.763
M07.30 Other psoriatic arthropathies (Multiple sites)	0.239	0.761
D55-D59 Haemolytic anaemias	0.240	0.760
H72.0 Central perforation of tympanic membrane	0.242	0.758
E73 Lactose intolerance	0.243	0.757
E66.0 Obesity due to excess calories	0.249	0.751
A50-A64 Infections with a predominantly sexual mode of transmission	0.251	0.749
E88 Other metabolic disorders	0.253	0.747
M45.X0 Ankylosing spondylitis (Multiple sites in spine)	0.254	0.746
H80 Otosclerosis	0.255	0.745
E10.3 With ophthalmic complications	0.255	0.744
L56 Other acute skin changes due to ultraviolet radiation	0.257	0.743
M00-M03 Infectious arthropathies	0.257	0.743
E10.9 Without complications	0.257	0.743
H65.9 Nonsuppurative otitis media, unspecified	0.259	0.741
E27.1 Primary adrenocortical insufficiency	0.262	0.738
B34.8 Other viral infections of unspecified site	0.267	0.733
L30 Other dermatitis	0.269	0.731
Chapter XXII Codes for special purposes	0.270	0.730
L05 Pilonidal cyst	0.274	0.726
E65 Localised adiposity	0.280	0.720
L02.3 Cutaneous abscess, furuncle and carbuncle of buttock	0.282	0.718
F00-F09 Organic, including symptomatic, mental disorders	0.282	0.718
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.283	0.717
E00 Congenital iodine-deficiency syndrome	0.283	0.717
E02 Subclinical iodine-deficiency hypothyroidism	0.283	0.717
E03.5 Myxoedema coma	0.283	0.717
E03.4 Atrophy of thyroid (acquired)	0.283	0.717
E03.3 Postinfectious hypothyroidism	0.283	0.717
E03.1 Congenital hypothyroidism without goitre	0.283	0.717
E03.0 Congenital hypothyroidism with diffuse goitre	0.283	0.717
Chapter XVI Certain conditions originating in the perinatal period	0.284	0.716
E80 Disorders of porphyrin and bilirubin metabolism	0.284	0.716
M35.0 Sicca syndrome [Sjogren]	0.284	0.716
L44 Other papulosquamous disorders	0.285	0.715
L41 Parapsoriasis	0.285	0.715
L45 Papulosquamous disorders in diseases classified elsewhere	0.285	0.715
L40.8 Other psoriasis	0.285	0.714
L40.4 Guttate psoriasis	0.285	0.714
L40.3 Pustulosis palmaris et plantaris	0.285	0.714
L40.2 Acrodermatitis continua	0.285	0.714
L40.1 Generalised pustular psoriasis	0.285	0.714
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.287	0.713
L58 Radiodermatitis	0.287	0.713
L55 Sunburn	0.287	0.713
L27 Dermatitis due to substances taken internally	0.288	0.711
E67 Other hyperalimentation	0.289	0.711
E68 Sequelae of hyperalimentation	0.289	0.711
M07.39 Other psoriatic arthropathies (Site unspecified)	0.289	0.711
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.289	0.710
L57.5 Actinic granuloma	0.289	0.710
L57.3 Poikiloderma of Civatte	0.289	0.710
L57.2 Cutis rhomboidalis nuchae	0.289	0.710
L57.1 Actinic reticuloid	0.289	0.710
M05.9 Seropositive rheumatoid arthritis, unspecified	0.291	0.709
E87.2 Acidosis	0.293	0.707
E66.1 Drug-induced obesity	0.293	0.707
D68.5 Primary Thrombophilia	0.293	0.707
D86.9 Sarcoidosis, unspecified	0.294	0.706
F30-F39 Mood [affective] disorders	0.295	0.705
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.296	0.704
M06.98 Rheumatoid arthritis, unspecified (Other)	0.296	0.703
F40-F48 Neurotic, stress-related and somatoform disorders	0.297	0.703
D50.1 Sideropenic dysphagia	0.297	0.703
E50-E64 Other nutritional deficiencies	0.297	0.703
F20-F29 Schizophrenia, schizotypal and delusional disorders	0.298	0.702
M14 Arthropathies in other diseases classified elsewhere	0.298	0.702
M06.8 Other specified rheumatoid arthritis	0.298	0.702
M06.2 Rheumatoid bursitis	0.298	0.702
M06.1 Adult-onset Still's disease	0.298	0.702
M12 Other specific arthropathies	0.299	0.701
M09 Juvenile arthritis in diseases classified elsewhere	0.299	0.701
M08 Juvenile arthritis	0.299	0.701
E10.1 With ketoacidosis	0.300	0.700
B25 Cytomegaloviral disease	0.300	0.700
H73 Other disorders of tympanic membrane	0.301	0.699
A92-A99 Arthropod-borne viral fevers and viral haemorrhagic fevers	0.301	0.698
A75-A79 Rickettsioses	0.301	0.698
A70-A74 Other diseases caused by chlamydiae	0.301	0.698
A65-A69 Other spirochaetal diseases	0.301	0.698
A20-A28 Certain zoonotic bacterial diseases	0.301	0.698
E74 Other disorders of carbohydrate metabolism	0.303	0.697
L04 Acute lymphadenitis	0.303	0.697
L01 Impetigo	0.303	0.697
L00 Staphylococcal scalded skin syndrome	0.303	0.697
M34 Systemic sclerosis	0.304	0.696
F80-F89 Disorders of psychological development	0.307	0.693
B24 Unspecified human immunodeficiency virus [HIV] disease	0.307	0.693
B48 Other mycoses, not elsewhere classified	0.307	0.692
B47 Mycetoma	0.307	0.692
B46 Zygomycosis	0.307	0.692
B45 Cryptococcosis	0.307	0.692
B43 Chromomycosis and phaeomycotic abscess	0.307	0.692
B42 Sporotrichosis	0.307	0.692
B41 Paracoccidioidomycosis	0.307	0.692
B40 Blastomycosis	0.307	0.692
B39 Histoplasmosis	0.307	0.692
B38 Coccidioidomycosis	0.307	0.692
B36 Other superficial mycoses	0.307	0.692
B37.7 Candidal septicaemia	0.309	0.691
B37.6 Candidal endocarditis	0.309	0.691
B37.5 Candidal meningitis	0.309	0.691
E06.9 Thyroiditis, unspecified	0.312	0.688
E84 Cystic fibrosis	0.312	0.688
E79 Disorders of purine and pyrimidine metabolism	0.312	0.688
E77 Disorders of glycoprotein metabolism	0.312	0.688
E76 Disorders of glycosaminoglycan metabolism	0.312	0.688
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.312	0.688
E72 Other disorders of amino-acid metabolism	0.312	0.688
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.312	0.688
E70 Disorders of aromatic amino-acid metabolism	0.312	0.688
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.312	0.688
D68.9 Coagulation defect, unspecified	0.314	0.686
L02.8 Cutaneous abscess, furuncle and carbuncle of other sites	0.314	0.686
L57.4 Cutis laxa senilis	0.318	0.681
A15-A19 Tuberculosis	0.320	0.680
H80.9 Otosclerosis, unspecified	0.321	0.679
L10-L14 Bullous disorders	0.323	0.677
H60-H62 Diseases of external ear	0.323	0.677
F60-F69 Disorders of adult personality and behaviour	0.323	0.677
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.323	0.677
H83 Other diseases of inner ear	0.327	0.673
M46 Other inflammatory spondylopathies	0.327	0.673
E14 Unspecified diabetes mellitus	0.328	0.672
B50-B64 Protozoal diseases	0.330	0.670
E40-E46 Malnutrition	0.331	0.668
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.332	0.668
M35.7 Hypermobility syndrome	0.332	0.668
L02.9 Cutaneous abscess, furuncle and carbuncle, unspecified	0.333	0.667
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.334	0.666
H68 Eustachian salpingitis and obstruction	0.334	0.666
H67 Otitis media in diseases classified elsewhere	0.334	0.666
H65.2 Chronic serous otitis media	0.335	0.665
H70 Mastoiditis and related conditions	0.335	0.664
B33 Other viral diseases, not elsewhere classified	0.336	0.664
B30 Viral conjunctivitis	0.336	0.664
B27 Infectious mononucleosis	0.336	0.664
B26 Mumps	0.336	0.664
L28 Lichen simplex chronicus and prurigo	0.336	0.664
E10.2 With renal complications	0.339	0.661
E03.8 Other specified hypothyroidism	0.341	0.659
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.341	0.659
E10.5 With peripheral circulatory complications	0.342	0.658
B15-B19 Viral hepatitis	0.342	0.658
D86.0 Sarcoidosis of lung	0.342	0.657
H72.1 Attic perforation of tympanic membrane	0.344	0.656
L24 Irritant contact dermatitis	0.344	0.656
L21 Seborrhoeic dermatitis	0.344	0.656
L26 Exfoliative dermatitis	0.344	0.656
L22 Diaper [napkin] dermatitis	0.344	0.656
M11 Other crystal arthropathies	0.344	0.656
H65.4 Other chronic nonsuppurative otitis media	0.345	0.655
E66.2 Extreme obesity with alveolar hypoventilation	0.346	0.654
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.346	0.654
E06.5 Other chronic thyroiditis	0.349	0.651
E06.4 Drug-induced thyroiditis	0.349	0.651
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.349	0.651
E06.1 Subacute thyroiditis	0.349	0.651
E06.0 Acute thyroiditis	0.349	0.651
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.350	0.650
L20 Atopic dermatitis	0.352	0.648
B37.9 Candidiasis, unspecified	0.352	0.648
D52 Folate deficiency anaemia	0.354	0.646
B35.1 Tinea unguium	0.354	0.646
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.355	0.645
B90-B94 Sequelae of infectious and parasitic diseases	0.357	0.643
D60-D64 Aplastic and other anaemias	0.357	0.643
M07.6 Other enteropathic arthropathies	0.357	0.643
M07.5 Arthropathy in ulcerative colitis	0.357	0.643
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.357	0.643
M07.2 Psoriatic spondylitis	0.357	0.643
M07.1 Arthritis mutilans	0.357	0.643
M07.0 Distal interphalangeal psoriatic arthropathy	0.357	0.643
M06.4 Inflammatory polyarthropathy	0.358	0.641
F31 Bipolar affective disorder	0.359	0.641
E85 Amyloidosis	0.359	0.641
D66 Hereditary factor VIII deficiency	0.361	0.639
B37.4 Candidiasis of other urogenital sites	0.362	0.638
D51 Vitamin B12 deficiency anaemia	0.362	0.638
D67 Hereditary factor IX deficiency	0.362	0.638
D65 Disseminated intravascular coagulation [defibrination syndrome]	0.362	0.638
L25 Unspecified contact dermatitis	0.362	0.637
E10.4 With neurological complications	0.364	0.636
B34.3 Parvovirus infection, unspecified	0.364	0.636
B34.2 Coronavirus infection, unspecified	0.364	0.636
B34.1 Enterovirus infection, unspecified	0.364	0.636
B34.0 Adenovirus infection, unspecified	0.364	0.636
B65-B83 Helminthiases	0.366	0.634
D69 Purpura and other haemorrhagic conditions	0.366	0.634
B37.1 Pulmonary candidiasis	0.367	0.633
B85-B89 Pediculosis, acariasis and other infestations	0.367	0.632
M45.X8 Ankylosing spondylitis (Sacral and sacrococcygeal region)	0.367	0.632
M45.X7 Ankylosing spondylitis (Lumbosacral region)	0.367	0.632
M45.X6 Ankylosing spondylitis (Lumbar region)	0.367	0.632
M45.X5 Ankylosing spondylitis (Thoracolumbar region)	0.367	0.632
M45.X4 Ankylosing spondylitis (Thoracic region)	0.367	0.632
M45.X3 Ankylosing spondylitis (Cervicothoracic region)	0.367	0.632
M45.X2 Ankylosing spondylitis (Cervical region)	0.367	0.632
M45.X1 Ankylosing spondylitis (Occipito-atlanto-axial region)	0.367	0.632
Chapter IX Diseases of the circulatory system	0.368	0.632
E22 Hyperfunction of pituitary gland	0.368	0.632
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.369	0.631
D50.8 Other iron deficiency anaemias	0.369	0.631
B37.2 Candidiasis of skin and nail	0.370	0.629
E12 Malnutrition-related diabetes mellitus	0.371	0.629
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.371	0.629
E89.8 Other postprocedural endocrine and metabolic disorders	0.371	0.629
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.371	0.629
E89.5 Postprocedural testicular hypofunction	0.371	0.629
E89.4 Postprocedural ovarian failure	0.371	0.629
E89.1 Postprocedural hypoinsulinaemia	0.371	0.629
E87.7 Fluid overload	0.371	0.629
M06.3 Rheumatoid nodule	0.371	0.628
E07 Other disorders of thyroid	0.373	0.627
M99 Biomechanical lesions, not elsewhere classified	0.374	0.626
D70-D77 Other diseases of blood and blood-forming organs	0.375	0.625
M49 Spondylopathies in diseases classified elsewhere	0.375	0.624
D68.0 Von Willebrand's disease	0.376	0.624
F42 Obsessive-compulsive disorder	0.376	0.624
L05.0 Pilonidal cyst with abscess	0.377	0.623
B99 Other and unspecified infectious diseases	0.379	0.621
M91-M94 Chondropathies	0.379	0.621
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.379	0.620
L23 Allergic contact dermatitis	0.380	0.620
H65.3 Chronic mucoid otitis media	0.380	0.620
E05.9 Thyrotoxicosis, unspecified	0.380	0.620
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.380	0.620
M60-M63 Disorders of muscles	0.381	0.619
D59 Acquired haemolytic anaemia	0.381	0.619
E89.3 Postprocedural hypopituitarism	0.382	0.618
B34.4 Papovirus infection, unspecified	0.385	0.615
E05.5 Thyroid crisis or storm	0.386	0.614
E05.4 Thyrotoxicosis factitia	0.386	0.614
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.386	0.614
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.386	0.614
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.386	0.613
E73.9 Lactose intolerance, unspecified	0.388	0.612
E10.0 With coma	0.392	0.608
E10.7 With multiple complications	0.392	0.608
A63 Other predominantly sexually transmitted diseases, not elsewhere classified	0.392	0.608
L29.8 Other pruritus	0.393	0.607
H65.1 Other acute nonsuppurative otitis media	0.393	0.606
H65.0 Acute serous otitis media	0.393	0.606
L29.9 Pruritus, unspecified	0.394	0.606
M07.38 Other psoriatic arthropathies (Other)	0.399	0.601
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.399	0.601
M07.36 Other psoriatic arthropathies (Lower leg)	0.399	0.601
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.399	0.601
M07.34 Other psoriatic arthropathies (Hand)	0.399	0.601
M07.33 Other psoriatic arthropathies (Forearm)	0.399	0.601
M07.32 Other psoriatic arthropathies (Upper arm)	0.399	0.601
M07.31 Other psoriatic arthropathies (Shoulder region)	0.399	0.601
H82 Vertiginous syndromes in diseases classified elsewhere	0.400	0.600
F70-F79 Mental retardation	0.400	0.599
E27.4 Other and unspecified adrenocortical insufficiency	0.401	0.599
L08.8 Other specified local infections of skin and subcutaneous tissue	0.401	0.598
D84 Other immunodeficiencies	0.402	0.598
D83 Common variable immunodeficiency	0.402	0.598
D82 Immunodeficiency associated with other major defects	0.402	0.598
D81 Combined immunodeficiencies	0.402	0.598
L30.8 Other specified dermatitis	0.402	0.598
H69 Other disorders of Eustachian tube	0.402	0.597
M95.9 Acquired deformity of musculoskeletal system, unspecified	0.402	0.597
M95.8 Other specified acquired deformities of musculoskeletal system	0.402	0.597
M95.5 Acquired deformity of pelvis	0.402	0.597
M95.4 Acquired deformity of chest and rib	0.402	0.597
M95.3 Acquired deformity of neck	0.402	0.597
M95.2 Other acquired deformity of head	0.402	0.597
M95.1 Cauliflower ear	0.402	0.597
E89.2 Postprocedural hypoparathyroidism	0.403	0.597
D53 Other nutritional anaemias	0.403	0.597
D68.2 Hereditary deficiency of other clotting factors	0.404	0.596
E87.4 Mixed disorder of acid-base balance	0.405	0.595
L29.3 Anogenital pruritus, unspecified	0.409	0.591
L29.1 Pruritus scroti	0.409	0.591
F43 Reaction to severe stress, and adjustment disorders	0.409	0.590
M30 Polyarteritis nodosa and related conditions	0.410	0.590
E83 Disorders of mineral metabolism	0.410	0.590
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.410	0.590
L42 Pityriasis rosea	0.411	0.589
M34.9 Systemic sclerosis, unspecified	0.411	0.589
F81 Specific developmental disorders of scholastic skills	0.411	0.589
M05.8 Other seropositive rheumatoid arthritis	0.411	0.588
M05.3 Rheumatoid arthritis with involvement of other organs and systems	0.411	0.588
M05.2 Rheumatoid vasculitis	0.411	0.588
M05.1 Rheumatoid lung disease	0.411	0.588
M05.0 Felty's syndrome	0.411	0.588
L08.1 Erythrasma	0.413	0.587
L08.0 Pyoderma	0.413	0.587
I60-I69 Cerebrovascular diseases	0.413	0.587
M35.9 Systemic involvement of connective tissue, unspecified	0.415	0.585
M35.8 Other specified systemic involvement of connective tissue	0.415	0.585
M35.6 Relapsing panniculitis [Weber-Christian]	0.415	0.585
M35.5 Multifocal fibrosclerosis	0.415	0.585
M35.4 Diffuse (eosinophilic) fasciitis	0.415	0.585
M35.2 Behcet's disease	0.415	0.585
M35.1 Other overlap syndromes	0.415	0.585
D68.4 Acquired coagulation factor deficiency	0.416	0.584
D68.1 Hereditary factor XI deficiency	0.416	0.584
M22 Disorders of patella	0.417	0.583
M36 Systemic disorders of connective tissue in diseases classified elsewhere	0.417	0.583
M32 Systemic lupus erythematosus	0.417	0.583
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.418	0.582
L02.0 Cutaneous abscess, furuncle and carbuncle of face	0.418	0.582
L27.0 Generalised skin eruption due to drugs and medicaments	0.418	0.582
B23 Human immunodeficiency virus [HIV] disease resulting in other conditions	0.419	0.581
B22 Human immunodeficiency virus [HIV] disease resulting in other specified diseases	0.419	0.581
B21 Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms	0.419	0.581
B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases	0.419	0.581
F05 Delirium, not induced by alcohol and other psychoactive substances	0.420	0.580
M46.9 Inflammatory spondylopathy, unspecified	0.423	0.577
B35.3 Tinea pedis	0.423	0.577
M00 Pyogenic arthritis	0.423	0.577
E14.9 Without complications	0.424	0.576
I70-I79 Diseases of arteries, arterioles and capillaries	0.425	0.575
F20 Schizophrenia	0.426	0.574
E35 Disorders of endocrine glands in diseases classified elsewhere	0.428	0.572
E32 Diseases of thymus	0.428	0.572
E31 Polyglandular dysfunction	0.428	0.572
E30 Disorders of puberty, not elsewhere classified	0.428	0.572
E25 Adrenogenital disorders	0.428	0.572
E20 Hypoparathyroidism	0.428	0.572
H72.2 Other marginal perforations of tympanic membrane	0.430	0.570
E10.8 With unspecified complications	0.430	0.569
L40.0 Psoriasis vulgaris	0.431	0.569
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.432	0.568
F42.9 Obsessive-compulsive disorder, unspecified	0.432	0.568
L43 Lichen planus	0.434	0.566
B37.3 Candidiasis of vulva and vagina	0.435	0.564
M06.08 Seronegative rheumatoid arthritis (Other)	0.436	0.564
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.436	0.564
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.436	0.564
M06.04 Seronegative rheumatoid arthritis (Hand)	0.436	0.564
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.436	0.564
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.436	0.564
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.436	0.564
L56.8 Other specified acute skin changes due to ultraviolet radiation	0.437	0.563
F99-F99 Unspecified mental disorder	0.437	0.563
B35.9 Dermatophytosis, unspecified	0.437	0.562
B35.8 Other dermatophytoses	0.437	0.562
B35.6 Tinea cruris	0.437	0.562
B35.5 Tinea imbricata	0.437	0.562
B35.4 Tinea corporis	0.437	0.562
B35.2 Tinea manuum	0.437	0.562
B35.0 Tinea barbae and tinea capitis	0.437	0.562
I20-I25 Ischaemic heart diseases	0.438	0.562
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.440	0.560
F30 Manic episode	0.440	0.560
H72.8 Other perforations of tympanic membrane	0.440	0.560
H83.0 Labyrinthitis	0.444	0.556
M10 Gout	0.445	0.555
F40 Phobic anxiety disorders	0.445	0.555
A80-A89 Viral infections of the central nervous system	0.445	0.555
I21 Acute myocardial infarction	0.445	0.555
D64 Other anaemias	0.446	0.554
D86.3 Sarcoidosis of skin	0.447	0.553
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.447	0.553
D86.1 Sarcoidosis of lymph nodes	0.447	0.553
F22 Persistent delusional disorders	0.447	0.553
E26 Hyperaldosteronism	0.448	0.552
D68.6 Other Thrombophilia	0.449	0.551
E87.8 Other disorders of electrolyte and fluid balance, not elsewhere classified	0.449	0.551
Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified	0.449	0.551
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.449	0.551
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.451	0.549
B95-B98 Bacterial, viral and other infectious agents	0.451	0.549
B49 Unspecified mycosis	0.453	0.547
F60 Specific personality disorders	0.453	0.547
E27.5 Adrenomedullary hyperfunction	0.453	0.547
E27.3 Drug-induced adrenocortical insufficiency	0.453	0.547
E27.2 Addisonian crisis	0.453	0.547
E27.0 Other adrenocortical overactivity	0.453	0.547
I69 Sequelae of cerebrovascular disease	0.453	0.547
E10.6 With other specified complications	0.454	0.546
D57 Sickle-cell disorders	0.455	0.545
D56 Thalassaemia	0.455	0.545
D55 Anaemia due to enzyme disorders	0.455	0.545
M34.1 CR(E)ST syndrome	0.457	0.543
E73.8 Other lactose intolerance	0.457	0.543
E73.1 Secondary lactase deficiency	0.457	0.543
E73.0 Congenital lactase deficiency	0.457	0.543
I73 Other peripheral vascular diseases	0.457	0.543
M33 Dermatopolymyositis	0.458	0.542
F00 Dementia in Alzheimer's disease	0.458	0.542
E87.5 Hyperkalaemia	0.458	0.542
F25 Schizoaffective disorders	0.458	0.542
E80.4 Gilbert's syndrome	0.458	0.542
M13 Other arthritis	0.459	0.541
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.462	0.537
E87.3 Alkalosis	0.462	0.538
B25.9 Cytomegaloviral disease, unspecified	0.462	0.537
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.463	0.537
A59 Trichomoniasis	0.463	0.537
A56 Other sexually transmitted chlamydial diseases	0.463	0.537
A54 Gonococcal infection	0.463	0.537
A53 Other and unspecified syphilis	0.463	0.537
A52 Late syphilis	0.463	0.537
A51 Early syphilis	0.463	0.537
A50 Congenital syphilis	0.463	0.537
A64 Unspecified sexually transmitted disease	0.463	0.537
A58 Granuloma inguinale	0.463	0.537
A57 Chancroid	0.463	0.537
A55 Chlamydial lymphogranuloma (venereum)	0.463	0.537
E88.9 Metabolic disorder, unspecified	0.464	0.536
E88.8 Other specified metabolic disorders	0.464	0.536
E88.3 Tumour lysis syndrome	0.464	0.536
E88.1 Lipodystrophy, not elsewhere classified	0.464	0.536
H80.8 Other otosclerosis	0.466	0.534
H80.2 Cochlear otosclerosis	0.466	0.534
H80.1 Otosclerosis involving oval window, obliterative	0.466	0.534
H80.0 Otosclerosis involving oval window, nonobliterative	0.466	0.534
L50-L54 Urticaria and erythema	0.466	0.534

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations